Many in the life sciences industry think we are doing our best to include patients in every point of drug development from pre-IND through commercial. Here is an outstanding visual to help understand what we will be doing differently to comply with the FDA Patient-Focused Drug Development guidance (PFDD)

Social Media Auto Publish Powered By :